Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0000950170-24-135521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2024-12-11 | 2024-12-09 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | G - Gift | $0.00 | -20.0K | 2.20M | -0.9% | $0 |
| TI | 2024-12-11 | 2024-12-10 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $50.00 | -8,273 | 2.20M | -0.4% | -$413.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | G | D | 20,000 | $0.00 | 2,203,985 | I By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 | — | — | |
| 2 | Common | Common Stock | 2024-12-10 | S | D | 8,273 | $50.00 | 2,195,712 | I By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 | — | — |